Literature DB >> 25017465

Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1.

Sandeep Goyal1, Yi Xiao1, Ned A Porter2, Libin Xu2, F Peter Guengerich1.   

Abstract

Cytochrome P450 (P450 or CYP) 46A1 is expressed in brain and has been characterized by its ability to oxidize cholesterol to 24S-hydroxycholesterol. In addition, the same enzyme is known to further oxidize 24S-hydroxycholesterol to the 24,25- and 24,27-dihydroxy products, as well as to catalyze side-chain oxidations of 7α-hydroxycholesterol and cholestanol. As precursors in the biosynthesis of cholesterol, 7-dehydrocholesterol has not been found to be a substrate of P450 46A1 and desmosterol has not been previously tested. However, 24-hydroxy-7-dehydrocholesterol was recently identified in brain tissues, which prompted us to reexamine this enzyme and its potential substrates. Here we report that P450 46A1 oxidizes 7-dehydrocholesterol to 24-hydroxy-7-dehydrocholesterol and 25-hydroxy-7-dehydrocholesterol, as confirmed by LC-MS and GC-MS. Overall, the catalytic rates of formation increased in the order of 24-hydroxy-7-dehydrocholesterol < 24-hydroxycholesterol < 25-hydroxy-7-dehydrocholesterol from their respective precursors, with a ratio of 1:2.5:5. In the case of desmosterol, epoxidation to 24S,25-epoxycholesterol and 27-hydroxylation was observed, at roughly equal rates. The formation of these oxysterols in the brain may be of relevance in Smith-Lemli-Opitz syndrome, desmosterolosis, and other relevant diseases, as well as in signal transduction by lipids.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  24-hydroxy-7-dehydrocholesterol; 24S,25-epoxycholesterol; 25-hydroxy-7-dehydrocholesterol; 27-hydr­oxydesmosterol

Mesh:

Substances:

Year:  2014        PMID: 25017465      PMCID: PMC4617353          DOI: 10.1194/jlr.M051508

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

1.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

2.  Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Cedric Shackleton; Esther Roitman; Li Wei Guo; William K Wilson; Forbes D Porter
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

Review 3.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

4.  Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance.

Authors:  D C Muchmore; L P McIntosh; C B Russell; D E Anderson; F W Dahlquist
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

5.  Desmosterol levels in human foetal brain--a reassessment.

Authors:  R G Dennick; P D Dean; D A Abramovich
Journal:  J Neurochem       Date:  1973-04       Impact factor: 5.372

6.  A simple and rapid method to measure cholesterol binding to P450s and other proteins.

Authors:  Natalia Mast; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2005-04-16       Impact factor: 5.922

7.  Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.

Authors:  I Björkhem; L Starck; U Andersson; D Lütjohann; S von Bahr; I Pikuleva; A Babiker; U Diczfalusy
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

8.  Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.

Authors:  Natalia Mast; Casey Charvet; Irina A Pikuleva; C David Stout
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

9.  The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production.

Authors:  Josep Marcos; Li-Wei Guo; William K Wilson; Forbes D Porter; Cedric Shackleton
Journal:  Steroids       Date:  2004-01       Impact factor: 2.668

10.  Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols.

Authors:  Kersti Karu; Martin Hornshaw; Gary Woffendin; Karl Bodin; Mats Hamberg; Gunvor Alvelius; Jan Sjövall; John Turton; Yuqin Wang; William J Griffiths
Journal:  J Lipid Res       Date:  2007-01-24       Impact factor: 5.922

View more
  21 in total

Review 1.  Common structural features of cholesterol binding sites in crystallized soluble proteins.

Authors:  Anna N Bukiya; Alejandro M Dopico
Journal:  J Lipid Res       Date:  2017-04-18       Impact factor: 5.922

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2016-08-11       Impact factor: 3.739

Review 4.  Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders.

Authors:  L Xu; N A Porter
Journal:  Free Radic Res       Date:  2014-12-09

5.  Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.

Authors:  William J Griffiths; Jonas Abdel-Khalik; Peter J Crick; Michael Ogundare; Cedric H Shackleton; Karin Tuschl; Mei Kwun Kwok; Brian W Bigger; Andrew A Morris; Akira Honda; Libin Xu; Ned A Porter; Ingemar Björkhem; Peter T Clayton; Yuqin Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-11       Impact factor: 4.292

6.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

7.  Characterization of human adrenal cytochrome P450 11B2 products of progesterone and androstenedione oxidation.

Authors:  Sarah M Glass; Michael J Reddish; Stella A Child; Clayton J Wilkey; Donald F Stec; F Peter Guengerich
Journal:  J Steroid Biochem Mol Biol       Date:  2020-11-12       Impact factor: 4.292

Review 8.  Sterol regulation of developmental and oncogenic Hedgehog signaling.

Authors:  Vikas Daggubati; David R Raleigh; Navdar Sever
Journal:  Biochem Pharmacol       Date:  2021-06-07       Impact factor: 5.858

Review 9.  Current trends in oxysterol research.

Authors:  William J Griffiths; Jonas Abdel-Khalik; Thomas Hearn; Eylan Yutuc; Alwena H Morgan; Yuqin Wang
Journal:  Biochem Soc Trans       Date:  2016-04-15       Impact factor: 5.407

10.  Cytochrome P450 metabolism of the post-lanosterol intermediates explains enigmas of cholesterol synthesis.

Authors:  Jure Ačimovič; Sandeep Goyal; Rok Košir; Marko Goličnik; Martina Perše; Ales Belič; Žiga Urlep; F Peter Guengerich; Damjana Rozman
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.